$SOBI #Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum - Q1 favoured by COVID-19: Increased demand related to COVID-19 A well-positioned share to hold in the pandemic We reiterate our view that Sobi should outperform https://t.co/vFPJ1QCTlS #equity #stocks https://t.co/vVmwfOpreE